Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, pharmacokinetics, tissue distribution, metabolism, and dosimetry of two prostate cancer imaging agents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Molecular Insight Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED